Closed Loop Medicine (CLM) announces £1.3m grant funding from Innovate UK, Longwall Capital and IQ Capital as part of today’s IUK £16m funding announcement.

CLM is an early stage UK therapeutics company focused on care pathways, outcomes and the provision of dynamic personalised therapy regimens underpinned by digital health solutions. 

The company combines proven drugs with digital engagement, medical devices and behavioural therapeutic interventions enabling data capture of a whole care pathway. This data is then used to tailor and create personalised care regimens.